Relay Therapeutics, Inc.
RLAY· Nasdaq
RLAYRelay Therapeutics, Inc.
Filed Feb 24, 2022 · 10-K · 55 days after period end · 0000950170-22-001978
derived · Computed from the longer spans the company filed.
| Metric | Q4 2021dderived from reported figures | Q4 2020dderived from reported figures | Q4 2019dderived from reported figures |
|---|---|---|---|
| Revenue | $567.00K | — | — |
| Net Income | -$67.46M | $35.28M | -$23.91M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Relay Therapeutics, Inc. · CIK 1812364 · Engraved from SEC EDGAR
ended Dec 31, 2021 · filed Feb 24, 2022 · 55 d after period end
